Hepatitis B Vaccine Clinical Trial
NCT00000583 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2013-11-26
Summary
To determine the efficacy of a hepatitis vaccine in preventing hepatitis B.
Conditions
- Hepatitis B
- Hepatitis, Viral, Human
- Liver Diseases
Interventions
- BIOLOGICAL
-
hepatitis B vaccines
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 36 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1978-11-30
- Completion
- 1980-06-30
More Related Trials
-
Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)
NCT00240539 ·Status: COMPLETED ·Phase: PHASE4
-
The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines
NCT01203319 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults
NCT02203357 ·Status: COMPLETED ·Phase: PHASE4
-
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
NCT00322361 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths
NCT00107042 ·Status: COMPLETED ·Phase: PHASE2
-
Duration of Long-term Immunity After Hepatitis B Virus Immunization
NCT01182311 ·Status: COMPLETED
-
Immunity to Hepatitis B Vaccine
NCT03083158 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine
NCT02692170 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)
NCT00508833 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers
NCT02055365 ·Status: COMPLETED ·Phase: NA
-
A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection
NCT03038802 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers
NCT02153320 ·Status: COMPLETED ·Phase: PHASE1
-
Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination
NCT00984139 ·Status: COMPLETED ·Phase: PHASE4
-
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.
NCT06184230 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers
NCT00240500 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine
NCT00329576 ·Status: COMPLETED ·Phase: PHASE4
-
Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
NCT00335881 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder
NCT01847430 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
NCT00519649 ·Status: COMPLETED ·Phase: PHASE4
-
Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination
NCT01292421 ·Status: WITHDRAWN ·Phase: NA
-
Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults
NCT00697853 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B
NCT02901951 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays
NCT01098006 ·Status: COMPLETED ·Phase: NA
-
Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population
NCT03962881 ·Status: UNKNOWN ·Phase: PHASE4
-
Adolescents' Response to Hepatitis B Vaccine Booster Dose
NCT01341275 ·Status: UNKNOWN ·Phase: PHASE4